‌

US Patent 8486956 Forms of rifaximin and uses thereof

Patent 8486956 was granted and assigned to Salix Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Salix Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

84869560

Patent Inventor Names

Donglai Yang0

Petinka Vlahova0

Karen S. Gushurst0

Jeffrey S. Stults0

Date of Patent

July 16, 2013

Patent Application Number

127088360

Date Filed

February 19, 2010

Patent Primary Examiner

‌

Bruck Kifle

Patent abstract

The present invention relates to Rifaximin polymorphic forms, to their use in medicinal preparations and to therapeutic methods using them.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8486956 Forms of rifaximin and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API